Therapeutic Inertia in the Management of Proteinuria Among Type 2 Diabetes Patients in Hong Kong Primary Care Setting: Prevalence and Associated Risk Factors
Abstract Background: Proteinuria is a well-known predictor of poor renal and cardiovascular outcomes in T2DM patientsMethods: Objectives: To explore the prevalence of Therapeutic inertia (TI) on proteinuria management among T2DM patients in primary care and possible patients’ and doctors’ factors.Study design: Cross-sectional studySubjects: T2DM patients with microalbuminuria and macroalbuminuria from 1/1/2014 to 31/12/2015.Outcome assessments: The prevalence of TI on proteinuria management and its association patients’ factors and the working profile of the attending doctors.Results: 5, 163 (26.4%) patients had diabetic nephropathy (DMN) with micro- or macroalbuminuria. Among the sampled 385 patients with DMN, TI was found to be 40.3%. Doctor factors for higher TI rate include male sex and doctors with longer duration of clinical practice and who have never received any form of Family Medicine training. Patients factors include lower average systolic (SBP) and diastolic blood pressure reading. Patients’ SBP reading and microalbuminuria were negative association factor whereas doctor’s year of clinical practice being over 21 years and patients being treated with submaximal dose of medication were positive association factors to TI. Conclusions: TI is commonly present on proteinuria management among T2DM patients managed in the primary care. Patient’s systolic blood pressure reading, microalbuminuria level, Dr’s year of clinical practice and dose of ACEI/ARB were found to be associated with the presence of TI. Further study on the barriers and strategies to combat TI is needed to improve the clinical outcome among T2DM patients.